Clinical Trial

TRIFORMIS RESILIA Real-world Study Assessing Safety and Performance (TRIBLAZE Study)

Name: TRIFORMIS RESILIA Real-world Study Assessing Safety and Performance (TRIBLAZE Study) — clinical trial record (NCT07684313)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TRIBLAZE

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

TRIBLAZE is a prospective, observational, single-arm, multicenter study designed to collect real-world clinical outcomes in a minimum of 75 participants who will receive the Edwards Lifesciences TRIFORMIS RESILIA surgical tricuspid heart valve, Model 11300T.

Trial Details

NCT Number	NCT07684313
Lead Sponsor	Edwards Lifesciences
Conditions	Heart Valve Diseases, Heart Diseases, Cardiovascular Diseases, Tricuspid Valve Disease
Enrollment	75 participants
Start Date	2026-08
Primary Completion	2030-08 (estimated)
Study Completion	2034-12 (estimated)
Updated on ClinicalTrials.gov	2026-07-06